Federal Government Left With 63 Million Doses Of Hydroxychloroquine After FDA Revokes Emergency Use

The U.S. Food and Drug Administration (FDA) revoked the emergency use authorization of the antimalarial drugs hydroxychloroquine and chloroquine for the treatment of COVID-19 patients Monday, leaving the federal government with a combined surplus of around 65 million useless dosages. The agency, which is a component of the U.S. Department of Health and Human Services (HHS), cited the latest clinical data and medical studies in a statement Monday.On March 28, the FDA approved various entities to use the two drugs on hospitalized COVID-19 patients.Since then, the government has raced to accumula…

Read More